Sex Differences in Health-related Quality of Life in Patients with Keratinocyte Carcinomas

Overview

Journal Acta Derm Venereol

Specialty Dermatology

Date 2020 Dec 29

PMID 33372685

Citations 2

Authors

Francesca Sampogna

Andrea Paradisi

Maria Luisa Iemboli

Luca Fania

Francesco Ricci

Monica Napolitano

Damiano Abeni

Affiliations

Soon will be listed here.

Abstract

The difference between men and women in the impact of keratinocyte carcinomas on quality of life has not been widely studied. This study of 364 patients with keratinocyte carcinoma, measured quality of life using the self-administered 12-item Short Form Health Survey (SF-12) and Skindex-29. Results for both the physical and the mental components of SF-12 were worse in women than in men. For the mental component, women had significantly lower scores compared with men in almost all subgroups, based on demographic and clinical variables. The Skindex-29 emotions mean score was worse in women than in men. Women reported significantly higher level of worry that the disease could get worse and of developing scars, and more depression. On the other hand, men reported lower quality of sleep. The impact of keratinocyte carcinomas on quality of life is generally higher in women than in men. Such data may be important for tailored management of the disease in different categories of patients.

Citing Articles

An Unexpected Finding: Treatment History Associated with the Quality of Life in Chinese Patients with Port-Wine Stains.

Zhao Q, Liu L, Li X, Yang L, Jiang X Clin Cosmet Investig Dermatol. 2023; 16:1969-1975.

PMID: 37533495 PMC: 10391529. DOI: 10.2147/CCID.S421296.

Liu Q, Sha M, Xue B, Shen L, Li G, Cheng X Ann Transl Med. 2023; 11(3):150.

PMID: 36846015 PMC: 9951022. DOI: 10.21037/atm-22-6654.

References

Sampogna F, Tabolli S, Abeni D . Impact of different skin conditions on quality of life. G Ital Dermatol Venereol. 2013; 148(3):255-61. View

Berg M, Lindberg M . Possible gender differences in the quality of life and choice of therapy in acne. J Eur Acad Dermatol Venereol. 2010; 25(8):969-72. DOI: 10.1111/j.1468-3083.2010.03907.x. View

Oberyszyn T . Non-melanoma skin cancer: importance of gender, immunosuppressive status and vitamin D. Cancer Lett. 2008; 261(2):127-36. DOI: 10.1016/j.canlet.2008.01.009. View

Lewis K, Weinstock M . Trends in nonmelanoma skin cancer mortality rates in the United States, 1969 through 2000. J Invest Dermatol. 2007; 127(10):2323-7. DOI: 10.1038/sj.jid.5700897. View

Moser U, Andrianakis A, Pondorfer P, Wolf A, Graupp M, Weiland T . Sex-specific differences in patients with nonmelanoma skin cancer of the pinna. Head Neck. 2020; 42(9):2414-2420. PMC: 7496743. DOI: 10.1002/hed.26237. View

Rhee J, Matthews B, Neuburg M, Smith T, Burzynski M, Nattinger A . Skin cancer and quality of life: assessment with the Dermatology Life Quality Index. Dermatol Surg. 2004; 30(4 Pt 1):525-9. DOI: 10.1111/j.1524-4725.2004.30169.x. View

Blackford S, Roberts D, Salek M, Finlay A . Basal cell carcinomas cause little handicap. Qual Life Res. 1996; 5(2):191-4. DOI: 10.1007/BF00434740. View

Hawkins D, Jacobsen G, Johnson C, Lim H, Eide M . Self-reported quality of life after skin cancer in young adults. J Dermatolog Treat. 2014; 26(4):357-60. DOI: 10.3109/09546634.2014.991671. View

Sampogna F, Chren M, Melchi C, Pasquini P, Tabolli S, Abeni D . Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis. Br J Dermatol. 2006; 154(2):325-31. DOI: 10.1111/j.1365-2133.2005.06909.x. View

10.

Ware Jr J, Kosinski M, Keller S . A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996; 34(3):220-33. DOI: 10.1097/00005650-199603000-00003. View

11.

Heaton H, Lawrence N . Nonmelanoma skin cancer in women. Int J Womens Dermatol. 2019; 5(1):2-7. PMC: 6374707. DOI: 10.1016/j.ijwd.2018.08.007. View

12.

Gaulin C, Sebaratnam D, Fernandez-Penas P . Quality of life in non-melanoma skin cancer. Australas J Dermatol. 2014; 56(1):70-6. DOI: 10.1111/ajd.12205. View

13.

Chren M, Sahay A, Bertenthal D, Sen S, Landefeld C . Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma. J Invest Dermatol. 2007; 127(6):1351-7. DOI: 10.1038/sj.jid.5700740. View

14.

Karimkhani C, Boyers L, Dellavalle R, Weinstock M . It's time for "keratinocyte carcinoma" to replace the term "nonmelanoma skin cancer". J Am Acad Dermatol. 2014; 72(1):186-7. DOI: 10.1016/j.jaad.2014.09.036. View

15.

. Basal cell and squamous cell skin cancers. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2009; 2(1):6-27. DOI: 10.6004/jnccn.2004.0001. View

16.

Madan V, Lear J, Szeimies R . Non-melanoma skin cancer. Lancet. 2010; 375(9715):673-85. DOI: 10.1016/S0140-6736(09)61196-X. View

17.

Sampogna F, Paradisi A, Iemboli M, Ricci F, Sonego G, Abeni D . Comparison of quality of life between melanoma and non-melanoma skin cancer patients. Eur J Dermatol. 2019; 29(2):185-191. DOI: 10.1684/ejd.2019.3523. View

18.

Flohil S, Seubring I, van Rossum M, Coebergh J, de Vries E, Nijsten T . Trends in Basal cell carcinoma incidence rates: a 37-year Dutch observational study. J Invest Dermatol. 2012; 133(4):913-8. DOI: 10.1038/jid.2012.431. View

19.

Shi Q, Duvic M, Osei J, Hordinsky M, Norris D, Price V . Health-Related Quality of Life (HRQoL) in alopecia areata patients-a secondary analysis of the National Alopecia Areata Registry Data. J Investig Dermatol Symp Proc. 2013; 16(1):S49-50. DOI: 10.1038/jidsymp.2013.18. View

20.

Picardi A, Abeni D, Mazzotti E, Fassone G, Lega I, Ramieri L . Screening for psychiatric disorders in patients with skin diseases: a performance study of the 12-item General Health Questionnaire. J Psychosom Res. 2004; 57(3):219-23. DOI: 10.1016/S0022-3999(03)00619-6. View